Viral Vitalism

Source Library

Long-term weight loss effects of semaglutide in obesity without diabetes in SELECT

Nature Medicine is tracked in the Viral Vitalism canonical source library.

StudyPeer-reviewed research publisher
Source type
Study
Access type
Publisher
Publisher
Nature Medicine
Date
2024
Added
2026-06-19
Open original ->Source index

Trust profile

VV Source Trust Matrix v1.0

VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.

88

Peer-reviewed research publisher

Publisher type
Peer-reviewed journal
Bias profile
Moderate

This source is strongest for clinical outcomes and mechanism and weaker for regulatory status and trial discovery.

VV Source Fit Score 1.0

Fit by use case

Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.

Frameworks ->
Regulatory status
65/100
Context Source
Clinical outcomes
92/100
Primary Anchor
Mechanism
90/100
Primary Anchor
Safety
86/100
Strong Support
Consumer context
72/100
Context Source
Trial discovery
65/100
Context Source

Best used for

  • Primary studies
  • Systematic reviews
  • Mechanistic research

Weak for

  • Regulatory status
  • Universal consumer recommendations

Used in Viral Vitalism

Related studies

SELECTSemaglutide and cardiovascular outcomes in obesity without diabetes

Related sources

Topic tags

glp-1semaglutideselectweight-losslong-term-data

Vital Signals

Get the weekly health signal without the wellness fog.

A clean weekly brief covering longevity science, fitness, nutrition, medicine, health culture, and the claims worth questioning.

No spam. No selling your information. Unsubscribe anytime.

By subscribing, you agree to receive email from Viral Vitalism. Unsubscribe anytime. See our Privacy Policy.